Lv21
130 积分 2025-10-16 加入
SGLT2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes: A cohort study and meta-analysis
10天前
已完结
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice
10天前
已完结
Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes
10天前
已完结
Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis
11天前
已完结
The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout
12天前
已完结
In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes
12天前
已完结
High- versus low-dose losartan and uric acid: An analysis from HEAAL
1个月前
已完结
Effect of losartan on uric acid metabolism in children with proteinuric kidney disease: crossover randomized controlled clinical trial
1个月前
已完结
Serum uric acid-lowering effect of sacubitril/valsartan in hypertensive patients: evaluation by switching from angiotensin II receptor blockers
1个月前
已完结
Hyperuricemia in Chronic Kidney Disease: Emerging Pathophysiology and a Novel Therapeutic Strategy
1个月前
已完结
皖公网安备34019202002308
